Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Julphar
Chubb
Citi
Accenture
Healthtrust
Moodys
Boehringer Ingelheim
Mallinckrodt
US Department of Justice

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,933,097

« Back to Dashboard

Summary for Patent: 8,933,097
Title:Fexofenadine suspension formulation
Abstract: The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.
Inventor(s): Chrzan; Kazimierz (New Hope, PA), Haribhakti; Rajiv (Churchville, PA), Mermey; Matthew (Leawood, KS), Porcello; Curtis J. (Ewing, NJ), Silvey; Gary Lee (Overland Park, KS), Tran; Vinh (Leawood, KS), Agrawala; Prafulla (Kendall Park, NJ)
Assignee: Sanofi-Aventis U.S. LLC (Bridgewater, NJ)
Application Number:12/138,468
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 8,933,097

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sanofi Aventis Us CHILDREN'S ALLEGRA ALLERGY fexofenadine hydrochloride SUSPENSION;ORAL 201373-001 Jan 24, 2011 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Sanofi Aventis Us CHILDREN'S ALLEGRA HIVES fexofenadine hydrochloride SUSPENSION;ORAL 201373-002 Jan 24, 2011 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,933,097

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Costa Rica 9993 ➤ Subscribe
Cyprus 1109320 ➤ Subscribe
Germany 602006006870 ➤ Subscribe
Denmark 1965768 ➤ Subscribe
Dominican Republic P2006000274 ➤ Subscribe
Ecuador SP088532 ➤ Subscribe
Egypt 25866 ➤ Subscribe
European Patent Office 1965768 ➤ Subscribe
Spain 2327168 ➤ Subscribe
Jordan 2549 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Mallinckrodt
Dow
Moodys
Merck
Colorcon
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot